ArticleFrontiers in oncology2024

Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer.

Shixin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.